Protein sequencing method and reagents
US-9566335-B1 · Feb 14, 2017 · US
US12312377B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12312377-B2 |
| Application number | US-201916510794-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 12, 2019 |
| Priority date | Jul 13, 2018 |
| Publication date | May 27, 2025 |
| Grant date | May 27, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Aspects of the disclosure provide biconjugatable labels, labeled biomolecules, and methods of using and making the same.
Opening claim text (preview).
What is claimed is: 1. A labeled biomolecule of the formula: wherein: Q 1 and Q 2 are independently monomeric or oligomeric biomolecules; L 1 and L 2 are independently optionally substituted alkylene; and X − is a counterion or is absent. 2. The labeled biomolecule of claim 1 , wherein Q 1 and Q 2 are independently nucleosides, nucleotides, oligonucleotides, nucleic acids, or derivatives or fragments thereof. 3. The labeled biomolecule of claim 2 , wherein Q 1 and/or Q 2 form a first oligonucleotide strand. 4. The labeled biomolecule of claim 3 , further comprising a second oligonucleotide strand hybridized to the first oligonucleotide strand. 5. The labeled biomolecule of claim 1 , wherein a nucleoside polyphosphate is attached through a terminal phosphate to Q 1 and/or Q 2 . 6. The labeled biomolecule of claim 1 , wherein the labeled biomolecule is of the formula: wherein n is independently an integer from 1-20, inclusive. 7. The labeled biomolecule of claim 6 , wherein the labeled biomolecule is of the formula: 8. The labeled biomolecule of claim 7 , wherein the labeled biomolecule is of the formula: 9. The labeled biomolecule of claim 1 , wherein L 1 and L 2 are independently optionally substituted C 1-20 alkylene. 10. The labeled biomolecule of claim 9 , wherein L 1 and L 2 are independently optionally substituted C 1-10 alkylene. 11. The labeled biomolecule of claim 3 , wherein the first oligonucleotide strand comprises at least 10 and fewer than 200 nucleotides. 12. The labeled biomolecule of claim 11 , wherein the first oligonucleotide strand comprises at least 10 and fewer than 100 nucleotides. 13. The labeled biomolecule of claim 12 , wherein the first oligonucleotide strand comprises at least 10 and fewer than 50 nucleotides. 14. The labeled biomolecule of claim 1 , wherein Q 1 and Q 2 are independently oligonucleotides, nucleic acids, or derivatives or fragments thereof, and wherein Q 1 and Q 2 form a first oligonucleotide strand. 15. The labeled biomolecule of claim 14 , further comprising a second oligonucleotide strand hybridized to the first oligonucleotide strand.
Other synthetic dyes of known constitution · CPC title
the polymethine chain being part of an heterocyclic ring · CPC title
Phthaleins containing amino groups {; Phthalanes; Fluoranes; Phthalides; Rhodamine dyes; Phthaleins having heterocyclic aryl rings; Lactone or lactame forms of triarylmethane dyes} · CPC title
without C-boron linkages · CPC title
Methine dyes, e.g. cyanine dyes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.